FDA accepts for review supplemental biologics license application for self-administration of FluMist Quadrivalent – AstraZeneca
Potential to be the first and only self-administered flu vaccine ; AstraZeneca’s Supplemental Biologics License Application (sBLA) for the approval of a self- or caregiver-administered option for FluMist… read more.
